GENE ONLINE|News &
Opinion
Blog

LATEST
After Winning Approval for Its Painkiller in Thailand, Taiwan’s Lumosa Aims for Korea Nod
2022-01-02
China’s Hansoh Teams Up with Middle East Onco-Collaborator
2022-01-02
AstraZeneca, Ionis Close $3.5+ Billion Deal for Rare Protein Misfolding Disorder
2021-12-30
CStone Wins Hong Kong Approval for Gastrointestinal Tumor Drug
2021-12-29
Grand Pharma Inks $590+ Million Deal for China Rights to ITM’s Precision Radiopharmaceuticals
2021-12-28
AstraZeneca’s Covid-19 Booster and Antibody Cocktail Retains Neutralizing Ability against Omicron
2021-12-27
Quidel to Acquire Ortho Clinical for $6 billion to Diversify Diagnostics Portfolio
2021-12-24
FDA Gives Emergency Approval to Merck’s COVID-19 Pill after Giving Similar Nod to Pfizer’s Tablets
2021-12-24
As Regenerative Medicine Grows in Japan, Challenges Remain
2021-12-24
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
Novartis Books Gyroscope for $1.5 Billion in Pursuit of Gene Therapy for Blindness
2021-12-23
FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention
2021-12-22
Sanofi Bets $1 Billion on Preclinical Next-gen Immunotherapies
2021-12-22
Quebec-based Medicago Preps its Homegrown Plant-based COVID-19 Vaccine for Canada Approval, Touting Promising Phase 3 Data
2021-12-21
Novartis Licenses BeiGene’s Antibody for a Potential $2.8 Billion After Its Own Drug Disappoints
2021-12-21
1 103 104 105 106 107 218
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top